nprnews_____ = ||| lubuntu at wor2 1TXN|||Novavax COVID-19 Vaccine Effective, But Less So Against Variant In South Africa||| kickerpage = |||no kicker pagenpr for NPRNEWS||| summarynpr = |||Novavax says its COVID-19 vaccine is 89% effective at preventing illness, according to an interim analysis of a U.K. study. But the vaccine wasn't as effective against some viral variants.

Nurse Vash Deelchand inoculated Kate Bingham, chair of the U.K. government's vaccine task force, with a Novavax vaccine at the Royal Free Hospital in London in October.



Kirsty O'Connor - PA Images/PA Images via Getty Images


hide caption

toggle caption

Kirsty O'Connor - PA Images/PA Images via Getty Images

Coronavirus Updates

Novavax COVID-19 Vaccine Effective, But Less So Against Variant In South Africa

Novavax says its COVID-19 vaccine is 89% effective at preventing illness, according to an interim analysis of a U.K. study. But the vaccine wasn't as effective against some viral variants.